In this study, we found that miR‐541 expression, which is decreased in SCLC, inhibited SCLC via directly negatively regulating HMGA2 levels, which enriched the HMGA2 regulatory network during SCLC progression. Here, HMGA2 is linked to small cell lung carcinoma.